CONMED CORPORATION Deferred Tax Assets, Operating Loss Carryforwards
CONMED CORPORATION (CNMD) had Deferred Tax Assets, Operating Loss Carryforwards of $840.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-17
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $840.00K.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.70M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.81M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.72M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $840.00K 10-K · filed 2026-02-17 | |
| 2024-12-31 | $1.70M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $2.81M 10-K · filed 2025-02-18 | |
| 2022-12-31 | $12.72M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $18.38M 10-K · filed 2023-02-21 | |
| 2020-12-31 | $22.20M 10-K · filed 2022-02-22 | |
| 2019-12-31 | $3.68M 10-K · filed 2021-02-22 | |
| 2018-12-31 | $7.36M 10-K · filed 2020-02-24 | |
| 2017-12-31 | $11.09M 10-K · filed 2019-02-25 | |
| 2016-12-31 | $34.67M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $6.42M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $10.21M 10-K · filed 2016-02-23 | |
| 2013-12-31 | $6.45M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $7.72M 10-K · filed 2014-02-24 | $191.00K 10-K · filed 2013-02-25 |
| 2011-12-31 | $0.00 10-K · filed 2013-02-25 | |
| 2010-12-31 | $3.09M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |